Global Human
Microbiome Market, by Product Type (Foods, Diagnostic Devices/Kits, Drugs,
and Others), by Application (Therapeutics and Diagnostics), by Disease
Indication (Gastrointestinal Disorders, Metabolic Disorders, Women Health,
Cancer, and Others), by Distribution Channel (Hospital Pharmacy, Retail
Pharmacy, and Online Pharmacy), and by Region (North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 46,913.4
million in 2017, and is projected to exhibit a CAGR of 17.5% over the forecast
period (2018 – 2026).
High number of collaboration
activities between key players and academia Increasing number of collaboration
activities between various players in the market and between different players
and research institutes is expected to aid in the expansion and development of
novel medicines for variety of diseases. For instance, in 2017, AOBiome secured
US$ 30 million investment for advancing clinical research on systemic and
topical inflammatory disorders using novel bacterial platform from iCarbonX. It
is evident that such efforts are accelerating the research and development of
microbiome platform.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/182
Similarly, in 2017, Stanford
University School of Medicine and Vedanta Biosciences Inc. entered in research
collaboration to focus on food allergies in children and on patients with C.
difficile infection or graft-versus-host disease
Browse 36 Market Data Tables and
35 Figures spread through 220 Pages and in-depth TOC on ‘Human Microbiome
Market’- Global Forecast to 2026, by Product Type (Foods, Diagnostic
Devices/Kits, Drugs, and Others), by Application (Therapeutics, and
Diagnostics), by Disease Indication (Gastrointestinal Disorders, Metabolic
Disorders, Women Health, Cancer, and Others), by Distribution Channel (Hospital
Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America,
Latin America, Europe, Asia Pacific, Middle East, and Africa).
Growing incidence of disease
conditions in which human microbiome product is used. According to data given
by Centre for Disease Control and Prevention in October 2017, Clostridium
difficile infection (CDI) is one of the most common healthcare-associated
infections in the China and Hong Kong, affecting around 36.1 cases/100,000
person in 2014, an annual increase of 26%. According to study published in
Clinical Infectious Disease journal in 2015, about 25% to 33% of
antibiotic-associated diarrhea and 90% of pseudomembranous enteritis are caused
by CDI.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/human-microbiome-market-182
Key Takeaways of the Human
Microbiome Market:
The global human microbiome
market is expected to exhibit a CAGR of 17.5% over the forecast period, owing
to increasing prevalence of cardiopulmonary conditions, cancer, and renal
diseases.
Among product type, the foods
segment held a dominant position in the human microbiome market in 2017, owing
to high adoption of probiotics-based food and beverages for maintaining balance
of microbiomes
Among disease type, cancer
disease held a dominant position in the human microbiome market in 2017. In
September 2018, World Health Organization (WHO), stated that cancer is the
second largest cause of deaths globally.
Among application, diagnostics
segment held a dominant position in the human microbiome market in 2017, as
emergence of diagnosis in early stage of cancer and other diseases is proven to
be beneficial in disease management.
Key players operating in the
global human microbiome market include Enterome Bioscience, Yakult Honsha Co.,
Ltd., DuPont, Metabiomics Corporation, ViThera Pharmaceuticals, Second Genome Inc.,
AOBiome LLC, Seres Therapeutics, uBiome, Inc., Rebiotix, Inc., Synthetic
Biologics, Inc., MicroBiome Therapeutics LLC, Vedanta BioSciences, Osel, Inc.,
and Merck & Co., Inc.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/182
About
Coherent Market Insights:
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment